Cemil Bilir, M., & Can Sarisozen, P. (2017, July). Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller? Journal of Oncological Sciences.
Chicago Style (17th ed.) CitationCemil Bilir, M.D., and PhD Can Sarisozen. "Indoleamine 2,3-dioxygenase (IDO): Only an Enzyme or a Checkpoint Controller?" Journal of Oncological Sciences Jul. 2017.
MLA (9th ed.) CitationCemil Bilir, M.D., and PhD Can Sarisozen. "Indoleamine 2,3-dioxygenase (IDO): Only an Enzyme or a Checkpoint Controller?" Journal of Oncological Sciences, Jul. 2017.
Warning: These citations may not always be 100% accurate.
